Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
about
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@en
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@nl
type
label
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@en
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@nl
prefLabel
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@en
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@nl
P2093
P2860
P50
P1476
Pharmacogenetic Analysis of th ...... uorouracil (ECF) Chemotherapy.
@en
P2093
Alicia Okines
Andrew Wotherspoon
Clare Peckitt
David Cunningham
Massimo Rugge
Matthew Nankivell
Patrick Tan
Richie Soong
Ruth Langley
Sally Stenning
P2860
P304
P356
10.1158/1078-0432.CCR-16-3142
P407
P577
2017-10-02T00:00:00Z